AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,660,461 | -15.0% | 452,472 | +36.0% | 0.00% | 0.0% |
Q2 2023 | $5,481,643 | +67.2% | 332,624 | -7.1% | 0.00% | – |
Q1 2023 | $3,278,000 | +1862400.0% | 357,860 | +1362.9% | 0.00% | – |
Q4 2022 | $176 | -99.9% | 24,463 | -8.9% | 0.00% | – |
Q3 2022 | $135,000 | +125.0% | 26,852 | +8.0% | 0.00% | – |
Q2 2022 | $60,000 | -70.3% | 24,859 | -16.1% | 0.00% | – |
Q1 2022 | $202,000 | -10.2% | 29,620 | +6.3% | 0.00% | – |
Q4 2021 | $225,000 | -90.8% | 27,862 | -88.8% | 0.00% | – |
Q3 2021 | $2,434,000 | +74.0% | 248,464 | +19.5% | 0.00% | – |
Q2 2021 | $1,399,000 | -48.9% | 207,859 | -31.4% | 0.00% | – |
Q1 2021 | $2,739,000 | -11.3% | 303,041 | -34.4% | 0.00% | – |
Q4 2020 | $3,087,000 | +81.4% | 462,057 | +39.6% | 0.00% | – |
Q3 2020 | $1,702,000 | -39.7% | 331,044 | -5.2% | 0.00% | -100.0% |
Q2 2020 | $2,821,000 | +1467.2% | 349,222 | +1438.4% | 0.00% | – |
Q1 2020 | $180,000 | +5.3% | 22,700 | 0.0% | 0.00% | – |
Q4 2019 | $171,000 | +81.9% | 22,700 | 0.0% | 0.00% | – |
Q3 2019 | $94,000 | +46.9% | 22,700 | 0.0% | 0.00% | – |
Q2 2019 | $64,000 | +814.3% | 22,700 | +383.0% | 0.00% | – |
Q1 2019 | $7,000 | -41.7% | 4,700 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -42.9% | 4,700 | 0.0% | 0.00% | – |
Q3 2018 | $21,000 | -97.5% | 4,700 | -96.5% | 0.00% | – |
Q2 2018 | $833,000 | +5453.3% | 135,873 | +7563.5% | 0.00% | – |
Q4 2017 | $15,000 | -95.4% | 1,773 | -94.5% | 0.00% | – |
Q3 2017 | $329,000 | -55.1% | 32,423 | -51.2% | 0.00% | – |
Q2 2017 | $733,000 | – | 66,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |